Kennedy Capital Management, Inc. Sarepta Therapeutics, Inc. Transaction History
Kennedy Capital Management, Inc.
- $4.27 Billion
- Q3 2024
A detailed history of Kennedy Capital Management, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 25,681 shares of SRPT stock, worth $2.8 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
25,681Holding current value
$2.8 Million% of portfolio
0.08%Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
528Shares Held
84MCall Options Held
1.99MPut Options Held
1.36M-
Black Rock Inc. New York, NY10.3MShares$1.13 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$978 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$683 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$476 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$466 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.55B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...